Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Cerebrovascular Disorders

Free Subscription 03.06.2019 2 Acta Neurol Scand 1 Anesth Analg 3 BMC Neurol 2 BMJ 1 Eur J Vasc Endovasc Surg 2 J Neurol 1 JAMA 7 Lancet 9 Lancet Neurol 2 N Engl J Med 1 Nervenarzt 6 Neurology 1 Neuroradiology 2 PLoS One 7 Stroke

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neurol Scand

1. HUANG K, Hu Y, Wu Y, Ji Z, et al
   Exploratory Analysis of Oral Glibenclamide in Acute Ischemic Stroke.
   Acta Neurol Scand. 2019 May 29. doi: 10.1111/ane.13134.
   PubMed     Text format     Abstract available
   
   
2. PANA TA, Wood AD, Mamas MA, Clark AB, et al
   Myocardial infarction after acute ischaemic stroke: incidence, mortality, and risk factors.
   Acta Neurol Scand. 2019 May 29. doi: 10.1111/ane.13135.
   PubMed     Text format     Abstract available
   
   

   
   Anesth Analg

3. MILLER EC, Leffert L
   Stroke in Pregnancy: A Focused Update.
   Anesth Analg. 2019 May 20. doi: 10.1213/ANE.0000000000004203.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

4. PIGMAN J, Reisman DS, Pohlig RT, Wright TR, et al
   The development and feasibility of treadmill-induced fall recovery training applied to individuals with chronic stroke.
   BMC Neurol. 2019;19:102.
   PubMed     Text format     Abstract available
   
   
5. XIE D, Wang M, Chen X, Tuo HZ, et al
   A case report: 1-year follow-up of cerebral sparganosis mansoni with a stroke-like onset.
   BMC Neurol. 2019;19:105.
   PubMed     Text format     Abstract available
   
   
6. GAMBA M, Gilberti N, Premi E, Costa A, et al
   Intravenous fibrinolysis plus endovascular thrombectomy versus direct endovascular thrombectomy for anterior circulation acute ischemic stroke: clinical and infarct volume results.
   BMC Neurol. 2019;19:103.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

7. SEMINOG OO, Scarborough P, Wright FL, Rayner M, et al
   Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults.
   BMJ. 2019;365:l1778.
   PubMed     Text format     Abstract available
   
   
8. MAHASE E
   Living in a war zone increases heart disease and stroke risk years after conflict ends, study finds.
   BMJ. 2019;365:l2367.
   PubMed     Text format    
   
   

   
   Eur J Vasc Endovasc Surg

9. MURPHY SJX, Naylor AR, Ricco JB, Sillesen H, et al
   Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature.
   Eur J Vasc Endovasc Surg. 2019;57:199-211.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol

10. KALITA J, Misra UK, Singh VK, Dubey D, et al
    Predictors and outcome of status epilepticus in cerebral venous thrombosis.
    J Neurol. 2018 Dec 19. pii: 10.1007/s00415-018-9145.
    PubMed     Text format     Abstract available
    
    
11. WANG Y, Cheng W, Lian Y, Zhang J, et al
    Characteristics and relative factors of headache caused by cervicocerebral artery dissection.
    J Neurol. 2019;266:298-305.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

12. KOSTMAN JR
    Listen to Your Heart.
    JAMA. 2019;321:1769-1770.
    PubMed     Text format    
    
    

    
    Lancet

13. ZIAI WC, Tsiskaridze A
    Restarting antiplatelet therapy after intracerebral haemorrhage.
    Lancet. 2019 May 21. pii: S0140-6736(19)31094.
    PubMed     Text format    
    
    
14. CAMPBELL BCV, Ma H, Ringleb PA, Parsons MW, et al
    Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Lancet. 2019 May 21. pii: S0140-6736(19)31053.
    PubMed     Text format     Abstract available
    
    
15. RODGERS H, Bosomworth H, Krebs HI, van Wijck F, et al
    Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.
    Lancet. 2019 May 21. pii: S0140-6736(19)31055.
    PubMed     Text format     Abstract available
    
    
16. 
    Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    Lancet. 2019 May 21. pii: S0140-6736(19)30840.
    PubMed     Text format     Abstract available
    
    
17. BERNHARDT J, Mehrholz J
    Robotic-assisted training after stroke: RATULS advances science.
    Lancet. 2019 May 21. pii: S0140-6736(19)31156.
    PubMed     Text format    
    
    
18. COUTTS SB, Menon BK
    Late thrombolysis for stroke works, but how do we do it?
    Lancet. 2019 May 21. pii: S0140-6736(19)31095.
    PubMed     Text format    
    
    
19. BORNSTEIN NM, Saver JL, Diener HC, Gorelick PB, et al
    An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.
    Lancet. 2019 May 23. pii: S0140-6736(19)31192.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Neurol

20. AL-SHAHI SALMAN R, Minks DP, Mitra D, Rodrigues MA, et al
    Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30184.
    PubMed     Text format     Abstract available
    
    
21. THE LANCET NEUROLOGY
    Adding stroke to the political agenda in Europe.
    Lancet Neurol. 2019;18:513.
    PubMed     Text format    
    
    
22. TSIVGOULIS G, Katsanos AH
    Can cerebral microbleeds predict stroke recurrence?
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30194.
    PubMed     Text format    
    
    
23. WILSON D, Ambler G, Lee KJ, Lim JS, et al
    Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
    Lancet Neurol. 2019 May 22. pii: S1474-4422(19)30197.
    PubMed     Text format     Abstract available
    
    
24. CHRISTENSEN H
    Antiplatelets after intracerebral haemorrhage: treat the patient, not the brain imaging.
    Lancet Neurol. 2019 May 21. pii: S1474-4422(19)30189.
    PubMed     Text format    
    
    
25. TOYODA K, Uchiyama S, Yamaguchi T, Easton JD, et al
    Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Lancet Neurol. 2019;18:539-548.
    PubMed     Text format     Abstract available
    
    
26. FORD GA, Bhakta BB, Cozens A, Hartley S, et al
    Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2019;18:530-538.
    PubMed     Text format     Abstract available
    
    
27. HILL MD, Benavente OR
    The uncertain role for phosphodiesterase inhibitors in stroke prevention.
    Lancet Neurol. 2019;18:515-517.
    PubMed     Text format    
    
    
28. STINEAR CM
    Dopamine for motor recovery after stroke: where to from here?
    Lancet Neurol. 2019;18:514-515.
    PubMed     Text format    
    
    

    
    N Engl J Med

29. MACK MJ, Leon MB, Thourani VH, Makkar R, et al
    Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1814052.
    PubMed     Text format     Abstract available
    
    
30. POPMA JJ, Deeb GM, Yakubov SJ, Mumtaz M, et al
    Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1816885.
    PubMed     Text format     Abstract available
    
    

    
    Nervenarzt

31. SEIDEL G, Rottinger A, Lorenzen J, Kucken D, et al
    [Quality of life and disability after severe stroke and early neurological rehabilitation].
    Nervenarzt. 2019 May 28. pii: 10.1007/s00115-019-0740.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

32. ZHENG F, Yan L, Zhong B, Yang Z, et al
    Progression of cognitive decline before and after incident stroke.
    Neurology. 2019 May 24. pii: WNL.0000000000007716.
    PubMed     Text format     Abstract available
    
    
33. GANESH A, Galetta S
    Editors' note: Urinary cadmium concentration and the risk of ischemic stroke.
    Neurology. 2019;92:1071.
    PubMed     Text format    
    
    
34. KAWADA T
    Reader response: Urinary cadmium concentration and the risk of ischemic stroke.
    Neurology. 2019;92:1071-1072.
    PubMed     Text format    
    
    
35. HE K, Chen C
    Author response: Urinary cadmium concentration and the risk of ischemic stroke.
    Neurology. 2019;92:1072.
    PubMed     Text format    
    
    
36. LEBEAUX D, Klein I, Garcia G, Bruneel F, et al
    Teaching NeuroImages: Aspergillosis-induced vasculitis presenting as ischemic stroke in an immunocompetent patient.
    Neurology. 2019;92:e2618-e2619.
    PubMed     Text format    
    
    
37. LAPPIN JM, Darke S
    Methamphetamine: An emerging cause of intracerebral haemorrhage in young people.
    Neurology. 2019 May 29. pii: WNL.0000000000007667.
    PubMed     Text format    
    
    

    
    Neuroradiology

38. NANNONI S, Cereda CW, Sirimarco G, Lambrou D, et al
    Collaterals are a major determinant of the core but not the penumbra volume in acute ischemic stroke.
    Neuroradiology. 2019 May 23. pii: 10.1007/s00234-019-02224.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

39. JONES GD, James DC, Thacker M, Perry R, et al
    Gait-initiation onset estimation during sit-to-walk: Recommended methods suitable for healthy individuals and ambulatory community-dwelling stroke survivors.
    PLoS One. 2019;14:e0217563.
    PubMed     Text format     Abstract available
    
    
40. GAD H, Khan A, Akhtar N, Kamran S, et al
    Correction: Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke.
    PLoS One. 2019;14:e0217672.
    PubMed     Text format     Abstract available
    
    

    
    Stroke

41. KIM JT, Bae HJ
    Response by Kim and Bae to Letter Regarding Article, "Magnetic Resonance Imaging Versus Computed Tomography Angiography Based Selection for Endovascular Therapy in Patients With Acute Ischemic Stroke".
    Stroke. 2019;50:e161.
    PubMed     Text format    
    
    
42. 
    Correction to: Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
    Stroke. 2019;50:e175.
    PubMed     Text format    
    
    
43. SONODA T, Matsuzaki J, Yamamoto Y, Sakurai T, et al
    Serum MicroRNA-Based Risk Prediction for Stroke.
    Stroke. 2019;50:1510-1518.
    PubMed     Text format     Abstract available
    
    
44. ZHENG BK
    Letter by Zheng Regarding Article, "Magnetic Resonance Imaging Versus Computed Tomography Angiography Based Selection for Endovascular Therapy in Patients With Acute Ischemic Stroke".
    Stroke. 2019;50:e160.
    PubMed     Text format    
    
    
45. MENSING LA, Greving JP, Verhoeff TA, Rinkel GJE, et al
    Comparison of Rupture Risk of Intracranial Aneurysms Between Familial and Sporadic Patients.
    Stroke. 2019;50:1380-1383.
    PubMed     Text format     Abstract available
    
    
46. KORLEY FK, Goldstick J, Mastali M, Van Eyk JE, et al
    Serum NfL (Neurofilament Light Chain) Levels and Incident Stroke in Adults With Diabetes Mellitus.
    Stroke. 2019 May 29:STROKEAHA119024941. doi: 10.1161/STROKEAHA.119.024941.
    PubMed     Text format     Abstract available
    
    
47. 
    Correction to: Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative.
    Stroke. 2019;50:e176.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cerebrovascular Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: